Daxor Price to Book Ratio 2010-2011 | DXR
Historical price to book ratio values for Daxor (DXR) over the last 10 years. The current price to book ratio for Daxor as of November 20, 2024 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Daxor Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2024-11-19 | 8.99 | 1.04 | |
| 2011-12-31 | 8.64 | $8.62 | 1.00 |
| 2011-09-30 | 9.93 | $8.92 | 1.11 |
| 2011-06-30 | 9.57 | $10.79 | 0.89 |
| 2011-03-31 | 9.51 | $10.91 | 0.87 |
| 2010-12-31 | 8.58 | $11.12 | 0.77 |
| 2010-09-30 | 8.00 | $11.43 | 0.70 |
| 2010-06-30 | 8.55 | $13.62 | 0.63 |
| 2010-03-31 | 9.50 | $10.98 | 0.86 |
| 2009-12-31 | 10.15 | $11.21 | 0.91 |
| 2009-09-30 | 9.19 | $11.82 | 0.78 |
| 2009-06-30 | 7.93 | $10.60 | 0.75 |
| 2009-03-31 | 11.89 | $7.47 | 1.59 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $0.043B | $0.000B |
| Daxor Corporation is a medical device manufacturing corporation with additional biotech services. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $19.458B | 11.77 |
| Quest Diagnostics (DGX) | United States | $17.988B | 18.23 |
| DaVita (DVA) | United States | $12.872B | 16.65 |
| Encompass Health (EHC) | United States | $9.984B | 23.54 |
| Chemed (CHE) | United States | $8.238B | 25.32 |
| Elanco Animal Health (ELAN) | United States | $6.580B | 15.66 |
| RadNet (RDNT) | United States | $5.911B | 130.90 |
| Option Care Health (OPCH) | United States | $3.713B | 17.60 |
| Amedisys (AMED) | United States | $2.948B | 20.98 |
| LifeStance Health (LFST) | United States | $2.770B | 0.00 |
| Astrana Health (ASTH) | United States | $2.302B | 31.49 |
| Addus HomeCare (ADUS) | United States | $2.180B | 25.57 |
| U.S Physical Therapy (USPH) | United States | $1.368B | 35.96 |
| Aveanna Healthcare Holdings (AVAH) | United States | $1.121B | 0.00 |
| Pennant (PNTG) | United States | $1.093B | 44.18 |
| Atai Life Sciences (ATAI) | Germany | $0.290B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.015B | 0.00 |
| Psychemedics (PMD) | United States | $0.014B | 0.00 |
| ATI Physical Therapy (ATIP) | United States | $0.008B | 0.00 |
| Ontrak (OTRK) | United States | $0.008B | 0.00 |
| IMAC Holdings (BACK) | United States | $0.001B | 0.00 |